Literature DB >> 19325002

Tat-binding protein-1 (TBP-1), an ATPase of 19S regulatory particles of the 26S proteasome, enhances androgen receptor function in cooperation with TBP-1-interacting protein/Hop2.

Tetsurou Satoh1, Takahiro Ishizuka, Takuya Tomaru, Satoshi Yoshino, Yasuyo Nakajima, Koshi Hashimoto, Nobuyuki Shibusawa, Tsuyoshi Monden, Masanobu Yamada, Masatomo Mori.   

Abstract

The 26S proteasome, which degrades ubiquitinated proteins, appears to contribute to the cyclical loading of androgen receptor (AR) to androgen response elements of target gene promoters; however, the mechanism whereby the 26S proteasome modulates AR recruitment remains unknown. Using yeast two-hybrid screening, we previously identified Tat-binding protein-1 (TBP-1), an adenosine triphosphatase of 19S regulatory particles of the 26S proteasome, as a transcriptional coactivator of thyroid hormone receptor. Independently, TBP-1-interacting protein (TBPIP) was also identified as a coactivator of several nuclear receptors, including AR. Here, we investigated whether TBP-1 could interact with and modulate transcriptional activation by AR cooperatively with TBPIP. TBP-1 mRNA was ubiquitously expressed in human tissues, including the testis and prostate, as well as in LNCaP cells. TBP-1 directly bound TBPIP through the amino-terminal domain possessing the leucine zipper structure. AR is physically associated with TBP-1 and TBPIP in vitro and in LNCaP cells. TBP-1 similarly and additively augmented AR-mediated transcription upon coexpression with TBPIP, and the ATPase domain, as well as leucine zipper structure in TBP-1, was essential for transcriptional enhancement. Overexpression of TBP-1 did not alter AR protein and mRNA levels. In the chromatin immunoprecipitation assay, TBP-1 was transiently recruited to the proximal androgen response element of the prostate-specific antigen gene promoter in a ligand-dependent manner in LNCaP cells. These findings suggest that a component of 19S regulatory particles directly binds AR and might participate in AR-mediated transcriptional activation in cooperation with TBPIP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19325002      PMCID: PMC2703560          DOI: 10.1210/en.2008-1122

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  33 in total

Review 1.  Emerging roles of ubiquitin in transcription regulation.

Authors:  Ronald C Conaway; Christopher S Brower; Joan Weliky Conaway
Journal:  Science       Date:  2002-05-17       Impact factor: 47.728

Review 2.  How the ubiquitin-proteasome system controls transcription.

Authors:  Masafumi Muratani; William P Tansey
Journal:  Nat Rev Mol Cell Biol       Date:  2003-03       Impact factor: 94.444

3.  A cDNA for a protein that interacts with the human immunodeficiency virus Tat transactivator.

Authors:  P Nelbock; P J Dillon; A Perkins; C A Rosen
Journal:  Science       Date:  1990-06-29       Impact factor: 47.728

4.  A nonproteolytic function of the 19S regulatory subunit of the 26S proteasome is required for efficient activated transcription by human RNA polymerase II.

Authors:  Anwarul Ferdous; Thomas Kodadek; Stephen Albert Johnston
Journal:  Biochemistry       Date:  2002-10-22       Impact factor: 3.162

5.  Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex.

Authors:  Zhigang Kang; Asta Pirskanen; Olli A Jänne; Jorma J Palvimo
Journal:  J Biol Chem       Date:  2002-10-09       Impact factor: 5.157

6.  Androgen-induced recruitment of RNA polymerase II to a nuclear receptor-p160 coactivator complex.

Authors:  Maggie C Louie; Hong Qiong Yang; Ai-Hong Ma; Wei Xu; June X Zou; Hsing-Jien Kung; Hong-Wu Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-14       Impact factor: 11.205

7.  Tat-binding protein-1, a component of the 26S proteasome, contributes to the E3 ubiquitin ligase function of the von Hippel-Lindau protein.

Authors:  Paul G Corn; E Robert McDonald; James G Herman; Wafik S El-Deiry
Journal:  Nat Genet       Date:  2003-10-12       Impact factor: 38.330

8.  Functional and physical interaction of the human ARF tumor suppressor with Tat-binding protein-1.

Authors:  Alessandra Pollice; Vittorio Nasti; Raffaele Ronca; Maria Vivo; Marco Lo Iacono; Raffaele Calogero; Viola Calabrò; Girolama La Mantia
Journal:  J Biol Chem       Date:  2003-12-09       Impact factor: 5.157

9.  Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter.

Authors:  Raphaël Métivier; Graziella Penot; Michael R Hübner; George Reid; Heike Brand; Martin Kos; Frank Gannon
Journal:  Cell       Date:  2003-12-12       Impact factor: 41.582

10.  TBP-1 protects the human oncosuppressor p14ARF from proteasomal degradation.

Authors:  A Pollice; M Sepe; V R Villella; F Tolino; M Vivo; V Calabrò; G La Mantia
Journal:  Oncogene       Date:  2007-03-05       Impact factor: 9.867

View more
  13 in total

Review 1.  Ubiquitin and proteasomes in transcription.

Authors:  Fuqiang Geng; Sabine Wenzel; William P Tansey
Journal:  Annu Rev Biochem       Date:  2012-03-08       Impact factor: 23.643

Review 2.  Emerging roles of the 26S proteasome in nuclear hormone receptor-regulated transcription.

Authors:  Brian R Keppler; Trevor K Archer; H Karimi Kinyamu
Journal:  Biochim Biophys Acta       Date:  2010-08-20

3.  Identification of cellular proteins interacting with equine infectious anemia virus S2 protein.

Authors:  Lina Covaleda; Bich-Ty Gno; Fredrick J Fuller; Susan L Payne
Journal:  Virus Res       Date:  2010-04-24       Impact factor: 3.303

4.  Oncoprotein GT198 vaccination delays tumor growth in MMTV-PyMT mice.

Authors:  Bhagelu R Achyut; Hao Zhang; Kartik Angara; Nahid F Mivechi; Ali S Arbab; Lan Ko
Journal:  Cancer Lett       Date:  2020-02-12       Impact factor: 8.679

5.  Human ovarian cancer stroma contains luteinized theca cells harboring tumor suppressor gene GT198 mutations.

Authors:  Min Peng; Hao Zhang; Lahcen Jaafar; John I Risinger; Shuang Huang; Nahid F Mivechi; Lan Ko
Journal:  J Biol Chem       Date:  2013-10-04       Impact factor: 5.157

6.  THRAP3 interacts with HELZ2 and plays a novel role in adipocyte differentiation.

Authors:  Akiko Katano-Toki; Tetsurou Satoh; Takuya Tomaru; Satoshi Yoshino; Takahiro Ishizuka; Sumiyasu Ishii; Atsushi Ozawa; Nobuyuki Shibusawa; Takafumi Tsuchiya; Tsugumichi Saito; Hiroyuki Shimizu; Koshi Hashimoto; Shuichi Okada; Masanobu Yamada; Masatomo Mori
Journal:  Mol Endocrinol       Date:  2013-03-22

7.  Activation of a novel ubiquitin-independent proteasome pathway when RNA polymerase II encounters a protein roadblock.

Authors:  Yi Ban; Chia-Wen Ho; Ren-Kuo Lin; Yi Lisa Lyu; Leroy F Liu
Journal:  Mol Cell Biol       Date:  2013-08-12       Impact factor: 4.272

8.  GT198 Expression Defines Mutant Tumor Stroma in Human Breast Cancer.

Authors:  Zheqiong Yang; Min Peng; Liang Cheng; Kimya Jones; Nita J Maihle; Nahid F Mivechi; Lan Ko
Journal:  Am J Pathol       Date:  2016-03-18       Impact factor: 4.307

9.  GT198 Splice Variants Display Dominant-Negative Activities and Are Induced by Inactivating Mutations.

Authors:  Min Peng; Zheqiong Yang; Hao Zhang; Lahcen Jaafar; Guanghu Wang; Min Liu; Hernan Flores-Rozas; Jianming Xu; Nahid F Mivechi; Lan Ko
Journal:  Genes Cancer       Date:  2013-01

10.  Inactivating Mutations in GT198 in Familial and Early-Onset Breast and Ovarian Cancers.

Authors:  Min Peng; Janine L Bakker; Richard A Dicioccio; Johan J P Gille; Hua Zhao; Kunle Odunsi; Lara Sucheston; Lahcen Jaafar; Nahid F Mivechi; Quinten Waisfisz; Lan Ko
Journal:  Genes Cancer       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.